ArticleBioinformatics (Oxford, England)2020

FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2.

Alina Renz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.